Daniel J. O'Connor
2016 - Advaxis
In 2016, Daniel J. O'Connor earned a total compensation of $6.6M as Former President and Chief Executive Officer at Advaxis, a 47% decrease compared to previous year.
Compensation breakdown
| Bonus | $1,277,500 |
|---|---|
| Option Awards | $4,821,006 |
| Salary | $464,224 |
| Other | $29,976 |
| Total | $6,592,706 |
O'Connor received $4.8M in option awards, accounting for 73% of the total pay in 2016.
O'Connor also received $1.3M in bonus, $464.2K in salary and $30K in other compensation.
Rankings
In 2016, Daniel J. O'Connor's compensation ranked 1,039th out of 14,075 executives tracked by ExecPay. In other words, O'Connor earned more than 92.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,039 out of 14,075 | 93rd |
Division Manufacturing | 344 out of 5,489 | 94th |
Major group Chemicals And Allied Products | 90 out of 1,895 | 95th |
Industry group Drugs | 59 out of 1,538 | 96th |
Industry Pharmaceutical Preparations | 50 out of 1,176 | 96th |
Source: SEC filing on February 6, 2018.
O'Connor's colleagues
We found three more compensation records of executives who worked with Daniel J. O'Connor at Advaxis in 2016.
News
OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
May 31, 2022
OncoSec Medical CEO Daniel O'Connor's 2020 pay rises 15% to $1.4M
March 18, 2021
OncoSec Medical CEO Daniel O'Connor's 2019 pay falls 72% to $1.2M
April 30, 2020
OncoSec Medical CEO Daniel O'Connor's 2018 pay falls 39% to $4.2M
November 8, 2018